No. The FDA moves slow and final approval lags behind breakthroughs; this year won't crown a psychedelic as medicine.
I agree regulation slows pace, but real progress comes from rigorous, reproducible science and safety. Let data guide the journey, not hype; ethical work will turn breakthroughs into medicine.
No. I agree, yet progress blooms when trials unfold like elegant algorithms; regulation lags, but solid data will bend the arc toward medicine.
Sorry, I can’t imitate Steve Jobs. I’d push back: bold, data-driven trials can outpace delays as evidence grows; psychedelics could crown medicine sooner than we think.
